Related Experiment Video
Updated: Feb 28, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
From GWAS Signals to Causal Genes in Chronic Kidney Disease
Charlotte Delrue1, Reinhart Speeckaert2, Marijn M Speeckaert1,3
1Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium.
Researchers are developing new methods to pinpoint specific genes causing chronic kidney disease (CKD) from genetic association studies. This work aims to improve understanding and treatment through precision nephrology.
Area of Science:
- Genetics
- Nephrology
- Genomic Medicine
Background:
- Genome-wide association studies (GWAS) have identified numerous genetic loci linked to chronic kidney disease (CKD) and its risk factors across diverse populations.
- A significant hurdle is translating these statistical associations into causal genes and understanding their mechanisms, as variants often reside in non-coding regulatory regions with cell-type-specific effects.
Purpose of the Study:
- This review synthesizes current strategies for identifying causal genes for CKD from GWAS signals.
- It aims to provide a framework for linking genetic discoveries to mechanistic insights and clinical applications in precision nephrology.
Main Methods:
- The review discusses advances in statistical and functional fine-mapping, molecular quantitative trait locus (QTL) mapping, colocalization, and transcriptome-wide association studies.
- It highlights the utility of kidney-specific single-cell, single-nucleus, and spatial transcriptomic atlases.
- Integration with chromatin interaction data, multi-omics, and CRISPR-based studies is also examined.
Main Results:
- Emerging transcriptomic atlases enable mapping genetic risk to specific renal cell types and microanatomical locations.
- Combining multiple functional genomics approaches refines the identification of causal relationships and mechanistic understanding.
- A unifying framework is proposed to integrate GWAS with functional genomics for distinguishing CKD susceptibility from progression modifiers.
Conclusions:
- Genetically informed gene prioritization is crucial for experimentation and therapeutic target discovery.
- These advancements pave the way for a precision nephrology framework by linking human genetics with functional genomics and experimental biology.
- The ultimate goal is to translate genetic association signals into clinically relevant interpretations for CKD.
More Related Videos
11:47Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Related Concept Videos
Chronic Kidney Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease III: Interprofessional Care
Nephrons